Clinical Trial Update: Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of gemcitabine and paclitaxel in patients with metastatic breast cancer; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-06-11